DANAHER CORPDHRバランスシート

時価総額
$1706.9億
PER
ライフサイエンス機器・試薬の大手。質量分析装置やレーザー走査顕微鏡、抗体試薬などのプロテオミクス製品を展開。2023年12月に主要プロテオミクス企業を約56億ドルで買収。北米・欧州・アジア中心に約60カ国で展開。
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
現金同等物1,6335371,6793,1153,00679196463078819,9126,0352,5865,9955,8642,078
現金 + 有価証券1,6335371,6793,1153,00679196463078819,9126,0352,5865,9955,8642,078
売掛金2,2193,0503,2673,4523,6343,9643,1863,5223,4903,1914,0454,6314,9183,9223,537
商品及び製品1,2251,7811,8131,7841,8322,0951,7091,8411,9101,6282,2922,7673,1102,5942,330
流動資産合計5,7306,2727,5889,1149,4317,8376,6656,8507,09425,59713,80211,64815,88313,9379,497
有形固定資産1,1922,1012,1412,2112,2032,8262,3542,4552,5112,3023,2623,7903,9564,5534,990
固定資産合計16,48823,67725,35325,55927,56040,38638,63039,79940,73936,48562,35971,53668,46770,55168,045
総資産22,21729,94932,94134,67236,99248,22245,29546,64947,83362,08276,16183,18484,35084,48877,542
一年内返済予定の長期借入金41--------------
流動負債合計3,3054,1724,2064,5275,3966,1706,8744,7924,8424,9327,4028,1408,3898,2746,798
長期借入金2,7845,2075,2883,4373,40212,0259,67410,3279,68921,51721,19322,16819,08616,70715,500
資本金及び資本剰余金788888888899999
利益剰余金10,94613,05715,38018,00520,32321,01220,70422,80625,16324,16627,15932,82739,20541,07444,188
株主資本13,77316,97219,08422,45123,45023,76423,07726,36828,22730,28239,77745,17750,09053,49049,550
有利子負債合計2,8255,2075,2883,4373,40212,0259,67410,3279,68921,51721,19322,16819,08616,70715,500
純有利子負債1,1924,6703,60932239611,2348,7119,6978,9011,60515,15819,58213,09110,84313,422
DEレシオ(%)20.530.727.715.314.550.641.939.234.371.153.349.138.131.231.3